with all the latest ARMI news and events. We know your inbox is overflowing, so we promise to only share important news and events with you - we hate SPAM too.

Filter by

Women Leaders of Regenerative Medicine

Be Inspired / 4 March 2019

Today is International Women’s Day, a day that celebrates the achievements of women all around the globe and across the social, economic, cultural and political spectrum. This year, the theme of International Women’s Day is Balance for Better, which calls for a more gender-balanced world. To mark International Women’s Day, ARMI Group Leaders Professor Susie Nilsson (who also holds a position at CSIRO), Associate Professor Edwina McGlinn (also an EMBL - Australia Laboratory Group Leader), and Dr Jennifer Zenker spoke about their personal experiences as women in academia, the mindset and cultural shift that is needed to achieve real gender parity and their hopes for the future.

The principles of regenerative medicine can be theoretically applied to any cell type in the body. This means that regenerative medicine holds the potential to treat most illnesses, conditions and diseases. Specifically, regenerative medicine can be used to grow or repair organs, whether it be in the context of congenital disease, physical injury or aging.  

ARMI is delighted to welcome its newest Group Leader, Dr Gonzalo del Monte Nieto. A native Spaniard, Gonzalo brings with him the combined specialisation of developmental biology and heart research, which he has cultivated over the past thirteen years at the lab bench. Moving over from the Victor Chang Cardiac Research Institute in Sydney (having spent the previous seven years there), Melbourne was a welcome opportunity to continue his life in Australia and to take the next step in his career in a leadership position.

Regenerate Newsletter - January 2019

News / 6 February 2019

The January 2019 of the ARMI newsletter, Regenerate, is now available to view in the 'Resources' section. Here are some of the highlights for ARMI in January:

  • Welcome to ARMI's newest Group Leader, Gonzalo del Monte-Nieto
  • Our latest ARMI recruits
  • What's on at ARMI
  • ARC Grant Success
  • New Publication
  • Introducing Optogenetics Australia

Discover what other highlights have emerged and keep up to date with ARMI in the latest edition of Regenerate.

Regenerate Newsletter - December 2018

News / 20 December 2018

The December 2018 of the ARMI newsletter, Regenerate, is now available to view in the 'Resources' section. Here are some of the highlights for ARMI in December:

  • Regenerative Medicine: Today and Tomorrow
  • Nadinath Nillegoda: ARMI’s Newest Group Leader is tapping into the Brain
  • 2018 Director's Awards
  • New Publications
  • Welcome to our new UROP students

Discover what other highlights have emerged and keep up to date with ARMI in the latest edition of Regenerate.

ARMI is pleased to welcome its newest Group Leader, Dr Nadinath Nillegoda. Coming all the way from Sri Lanka with career pit-stops in the United States and Germany, Nadinath is now exploring the nexus between neurodegeneration and immunology, which provides him a niche in a quickly expanding research field. Neurodegenerative diseases, collectively, are the leading cause of disability among our aging communities and there is no effective cure. Since joining us in December, Nadinath has been hard at work setting up his research group in the pursuit of a better understanding of the molecular mechanisms that underpin neurodegenerative diseases. With hopes of pushing the boundaries of brain research, Nadinath is determined to improve the health outcomes for those with Alzheimer’s disease and dementia.

During this year's AusBiotech conference, held in October in Brisbane, MTPConnect released the report, Regenerative Medicine: Opportunities for Australia, in collaboration with the AusBiotech Regenerative Medicine Advisory Group and other key stakeholders, including the Centre for Commercialisation of Regenerative Medicine (CCRM) Australia. The report, a culmination of surveys, interviews and workshops with more than 60 key members and bodies in the sector, analyses the current state of regenerative medicine (RM) in Australia, its strengths and weaknesses, and provides a roadmap for advancing the sector to successfully compete on the global stage. While the document has a commercialisation and industry focus, it does emphasise the strength, importance and necessity of discovery research in RM.